Search Results for: search.php

Novel Inhibitors of Malassezia pachydermatis

Fungi (yeast) of the genus Malassezia are found on the skin of most humans and animals. In humans this disease is most commonly caused by Malassezia furfur. Infections with this pathogen can result in life-threatening fungemia and other nosocomial infections. Rare cases can be attributed to M. pachydermatis. Novel natural substances are provided, which show highly promising activity against M. pachydermatis. MIC values are comparable to those for terbinafine, which is a synthetic antifungal.

New method will enable most accurate neutron measurement yet

Researchers in an international collaboration at the Paul Scherrer Institute (PSI) have successfully developed a new experimental method to determine a…

What is the cost of lung cancer in Germany?

As part of their research, the team of scientists headed by Dr. Larissa Schwarzkopf and Prof. Reiner Leidl from the Institute of Health Economics and Health…

ACIP / Peptide-based Inhibition of Cancer Cachexia

Cachexia related to cancer, occurs in 30-70% of cancer patients and still represents an as-yet non-curable and fatal paraneoplastic syndrome in a variety of tumor entities. The present invention discloses a new method for preventing cancer cachexia based on preventing inhibition of the protein AMPK.

miRNA-375 and miRNA-141 as non-invasive markers for diagnosis and staging in prostate cancer

6% of all prostate cancer patients die due to their illness. However, 80% of all prostate cancer patients do not need therapy, since their cancers grow slowly. Since the mainly used marker (prostate-specific antigen, PSA) is also elevated in case of inflammatory processes or with benign prostatic hyperplasia, DKFZ inventors analysed serum samples and identified miRNA-375 and miRNA-141 as new biomarkers for high-risk tumors.

Therapy of brain tumors by inhibition of nuclear receptor tailles (Tlx)

DKFZ researchers identified nuclear receptor tailles (Tlx) as a valuable drug target for brain tumors especially gliobastomas. In vivo experiments showed almost doubling in survival time of mice harbouring brain tumors by inhibiting the expression of Tlx in tumor cells. In addition a highly significant correlation between expression of Tlx in brain tumor cells and survival of the patient was demonstrated.

Seite
1 395 396 397 398 399 1,597